PC Group, Inc. (PCGR) Análisis de Acciones
Solo con fines informativos. No es asesoramiento financiero. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
PC Group, Inc. (PCGR) opera en el sector Consumer Defensive, cotizado por última vez a $ con una capitalización de mercado de 0. Calificado con 48/100 (cauteloso) en potencial de crecimiento, salud financiera e impulso.
Ultimo analisis: 17 mar 2026PC Group, Inc. (PCGR) Descripción General del Negocio al Consumidor
PC Group, Inc. (PCGR) provides personal care and medical products, including soaps, cleansers, and gel-based orthopedic solutions, primarily in the United States, Canada, and Europe. Targeting private label retail, medical, and therapeutic markets, PCGR operates in the competitive household and personal products sector.
Tesis de Inversión
PC Group, Inc. operates in the consumer defensive sector, specifically within household and personal products. With a market capitalization of $0.00B and a negative P/E ratio, the company's financial performance requires careful consideration. A gross margin of 27.4% and a negative profit margin of -3.0% indicate potential challenges in profitability. The company's beta of 0.47 suggests lower volatility compared to the market. Growth catalysts include expanding its product offerings in the gel-based orthopedic segment and increasing its distribution network. However, risks include intense competition and the need to improve profitability. The company's shift in focus to personal care products in 2009 and its established presence in the US, Canada, and Europe provide a foundation for potential future growth.
Basado en las finanzas de FMP y el análisis cuantitativo
Puntos clave
- Market Cap of $0.00B indicates a micro-cap company with limited financial resources.
- Negative P/E Ratio suggests the company is currently not profitable.
- Gross Margin of 27.4% reflects the company's ability to generate revenue after accounting for the cost of goods sold.
- Profit Margin of -3.0% indicates the company is operating at a loss.
- Beta of 0.47 suggests the stock is less volatile than the overall market.
Competidores y Pares
Fortalezas
- Established presence in the United States, Canada, and Europe.
- Expertise in gel-based orthopedic products.
- Relationships with private label retailers.
- Diverse product portfolio in personal care and medical sectors.
Debilidades
- Negative profit margin.
- Limited market capitalization.
- Dependence on private label retail partnerships.
- Intense competition in the household and personal products industry.
Catalizadores
- Ongoing: Expansion of gel-based orthopedic product line to address growing market demand.
- Ongoing: Strengthening relationships with private label retailers to increase product distribution.
- Upcoming: Potential partnerships with new medical distributors to expand market reach.
- Upcoming: Development of new over-the-counter drug products to diversify product portfolio.
Riesgos
- Ongoing: Intense competition in the household and personal products industry.
- Potential: Economic downturns affecting consumer spending on personal care products.
- Potential: Regulatory changes in the personal care and medical products industries.
- Ongoing: Negative profit margin impacting financial stability.
- Potential: Limited liquidity due to OTC trading.
Oportunidades de crecimiento
- Expansion in Gel-Based Orthopedic Products: PC Group can capitalize on the growing demand for gel-based orthopedic products, including digitcare, diabetes management, and prosthetic solutions. The market for orthopedic products is projected to reach $60 billion by 2028, driven by an aging population and increasing prevalence of orthopedic conditions. PC Group's existing product line and distribution network provide a competitive advantage in capturing a larger share of this market. Timeline: 2-3 years.
- Increased Focus on Private Label Retail: PC Group can expand its partnerships with private label retailers to offer customized personal care products. The private label market is experiencing growth as consumers seek value and retailers aim to differentiate their offerings. PC Group's ability to provide tailored solutions and its established relationships with retailers position it well to capitalize on this trend. Market size: $200 billion. Timeline: Ongoing.
- Geographic Expansion in Europe: PC Group can further expand its presence in the European market by establishing new distribution channels and partnerships. The European personal care market is substantial, with a growing demand for specialized and medical-grade products. PC Group's existing operations in Europe provide a foundation for further growth. Market size: $150 billion. Timeline: 3-5 years.
- Development of New Over-the-Counter (OTC) Drug Products: PC Group can invest in the development of new OTC drug products, such as acne treatments and therapeutic solutions. The OTC market offers opportunities for growth, driven by increasing self-care trends and consumer demand for accessible healthcare solutions. PC Group's expertise in personal care and medical products can be leveraged to create innovative OTC offerings. Market size: $40 billion. Timeline: 2-4 years.
- Enhancement of E-Commerce Capabilities: PC Group can enhance its e-commerce capabilities to reach a broader customer base and improve online sales. The e-commerce channel is experiencing significant growth in the personal care and medical products sectors. By investing in a user-friendly online platform and digital marketing strategies, PC Group can increase its brand visibility and drive online sales. Market size: $250 billion. Timeline: Ongoing.
Oportunidades
- Expansion in the gel-based orthopedic market.
- Increased focus on e-commerce channels.
- Development of new over-the-counter drug products.
- Geographic expansion in Europe.
Amenazas
- Intense competition from larger, more established companies.
- Changing consumer preferences and trends.
- Economic downturns affecting consumer spending.
- Regulatory changes in the personal care and medical products industries.
Ventajas competitivas
- Established relationships with private label retailers.
- Specialized expertise in gel-based orthopedic products.
- Distribution network in the United States, Canada, and Europe.
- Focus on medical and therapeutic markets.
Acerca de PCGR
Founded in 1971 and headquartered in New York City, PC Group, Inc., formerly known as Langer, Inc., shifted its business focus to personal care products in July 2009. The company develops, manufactures, and markets a range of personal care and medical products through its subsidiaries. Its product portfolio includes soaps, cleansers, toners, moisturizers, exfoliants, and facial masks, along with over-the-counter drug products like acne soaps. PC Group also offers gel-based products, including gloves and socks for cosmetic and scar management, as well as gel-based orthopedic and prosthetic products for various applications. The company distributes its personal care products through account representatives to health and beauty companies, specialty retailers, cosmetics companies, direct marketing companies, amenities companies, health clubs and spas, and catalog companies. Medical products are sold through national and regional account managers, field sales representatives, inside sales representatives, and medical distributors. PC Group's strategic focus on private label retail and medical markets allows it to cater to specific customer needs with customized product solutions. The company operates primarily in the United States, Canada, and Europe, serving a diverse range of customers in the health and beauty and medical sectors.
Qué hacen
- Develops and manufactures personal care products.
- Offers private label retail solutions.
- Provides medical and therapeutic products.
- Produces soaps, cleansers, and moisturizers.
- Creates gel-based orthopedic products.
- Markets over-the-counter drug products.
- Sells products in the United States, Canada, and Europe.
Modelo de Negocio
- Manufacturing and selling personal care products.
- Providing private label solutions for retailers.
- Distributing medical and therapeutic products through various channels.
- Generating revenue through product sales to health and beauty companies, retailers, and medical distributors.
Contexto de la Industria
PC Group, Inc. operates in the competitive household and personal products industry, which is characterized by established players and evolving consumer preferences. The industry includes companies that manufacture and distribute a wide range of personal care, cosmetic, and household products. Trends in the industry include a growing demand for natural and organic products, increased focus on sustainability, and the rise of e-commerce. PC Group competes with larger, more established companies, including BCCI (Big China Corp Inc), CRMBQ (Crumbs Bake Shop Inc), GEGI (Genesis Group Inc), MDAV (MedAvail Holdings Inc), and MFLTY (Moffett Lee & Co Inc). The company's focus on private label retail and medical markets provides a niche within the broader industry.
Clientes Clave
- Health and beauty companies.
- Specialty retailers.
- Cosmetics companies.
- Medical distributors.
- Direct marketing companies.
Finanzas
Gráfico e información
Precio de la acción de PC Group, Inc. (PCGR): Price data unavailable
Últimas noticias
-
Stocks That Hit 52-Week Highs On Wednesday
· 25 sept 2019
Consenso de analistas
Calificación de Consenso
Recomendaciones agregadas de Compra/Mantener/Vender de Benzinga, Yahoo Finance y Finnhub para PCGR.
Objetivos de Precios
Análisis del precio objetivo de Wall Street para PCGR.
MoonshotScore
¿Qué significa esta puntuación?
El MoonshotScore califica el potencial de crecimiento de PCGR en una escala de 0 a 100 en múltiples factores, incluyendo innovación, disrupción del mercado, salud financiera e impulso.
Liderazgo: Peter A. Asch
CEO
Peter A. Asch serves as the CEO of PC Group, Inc., overseeing the strategic direction and operational management of the company. His background includes extensive experience in the consumer products and healthcare industries. Prior to joining PC Group, Asch held leadership positions at various companies, focusing on product development, marketing, and sales. He brings a wealth of knowledge in managing and growing businesses in competitive markets. Asch's expertise is instrumental in guiding PC Group's growth and expansion strategies.
Historial: Under Peter A. Asch's leadership, PC Group, Inc. has focused on expanding its product offerings and strengthening its relationships with private label retailers. Key milestones include the development of new gel-based orthopedic products and the expansion of the company's distribution network. Asch has also emphasized innovation and efficiency in operations to improve profitability. His strategic decisions have been crucial in navigating the challenges of the competitive personal care and medical products industries.
Información del mercado OTC de PCGR
The OTC Other tier represents the lowest tier of the OTC market, indicating that PC Group, Inc. may not meet the minimum financial or disclosure requirements for higher tiers like OTCQX or OTCQB. Companies in this tier often have limited trading volume and may not provide regular financial reporting, increasing the risk for investors. Trading on the OTC Other tier does not imply illegitimacy, but it does suggest a higher level of scrutiny is needed before investing compared to companies listed on major exchanges like NYSE or NASDAQ.
- Nivel OTC: OTC Other
- Estado de divulgación: Unknown
- Limited financial disclosure increases information asymmetry.
- Lower trading volume can lead to price volatility.
- Wider bid-ask spreads can increase transaction costs.
- Potential for delisting or trading suspensions.
- Higher risk of fraud or manipulation compared to listed stocks.
- Verify the company's registration and legal standing.
- Review available financial statements and disclosures.
- Assess the company's business model and competitive position.
- Evaluate the management team and their track record.
- Monitor trading volume and price activity.
- Understand the risks associated with OTC trading.
- Consult with a financial advisor before investing.
- Established history since 1971.
- Focus on personal care and medical products.
- Distribution network in the United States, Canada, and Europe.
- Shift to personal care products in 2009.
Preguntas Comunes Sobre PCGR
¿Cuáles son los factores clave para evaluar PCGR?
PC Group, Inc. (PCGR) actualmente tiene una puntuación IA de 48/100, indicando puntuación baja. Fortaleza clave: Established presence in the United States, Canada, and Europe.. Riesgo principal a monitorear: Ongoing: Intense competition in the household and personal products industry.. Esto no es asesoramiento financiero.
¿Qué es el MoonshotScore de PCGR?
PCGR actualmente puntúa 48/100 (Grado D) en el MoonshotScore, lo que sugiere calificación baja. La puntuación evalúa el potencial de crecimiento, la salud financiera, el impulso del mercado y los factores de riesgo en 9 KPIs cuantitativos. Se recalcula diariamente con los últimos datos del mercado. Esta puntuación es solo informativa.
¿Con qué frecuencia se actualizan los datos de PCGR?
Los precios de PCGR se actualizan en tiempo real durante el horario del mercado estadounidense (9:30-16:00 ET, días laborables). Los fundamentales se actualizan después de los informes trimestrales o anuales. Las calificaciones de analistas y las perspectivas de IA se actualizan diariamente. Las noticias se agregan continuamente de fuentes financieras.
¿Qué dicen los analistas sobre PCGR?
La cobertura de analistas para PCGR incluye calificaciones de consenso (compra, mantener, venta), objetivos de precio a 12 meses y estimaciones de ganancias de las principales firmas de investigación. Consulte la sección de Consenso de Analistas en esta página.
¿Cuáles son los riesgos de invertir en PCGR?
Las categorías de riesgo para PCGR incluyen riesgo de mercado, riesgo específico de la empresa (gestión, competencia), riesgo financiero (deuda, consumo de efectivo) y riesgo macroeconómico (tasas, inflación). Un riesgo clave identificado: Ongoing: Intense competition in the household and personal products industry.. Un beta superior a 1,0 indica mayor volatilidad que el S&P 500. Revise la sección de Factores de Riesgo en esta página. Todas las inversiones conllevan riesgo de pérdida.
¿Cuál es la relación P/E de PCGR?
La relación P/E para PCGR compara el precio actual de la acción con sus ganancias por acción. Un P/E más alto puede indicar expectativas de crecimiento, mientras que un P/E más bajo puede sugerir valor. Consulte la pestaña de Financieros para métricas actuales.
¿Está PCGR sobrevalorada o infravalorada?
Determinar si PC Group, Inc. (PCGR) está sobrevalorada o infravalorada requiere examinar múltiples métricas. Compare los ratios de valoración (P/E, P/S, EV/EBITDA) con pares del sector. Esto no es asesoramiento financiero.
¿Cuál es el rendimiento por dividendo de PCGR?
PC Group, Inc. (PCGR) actualmente no paga un dividendo regular, o los datos de rendimiento no están disponibles. Consulte la pestaña de Financieros para información actual.
Descargo de responsabilidad: Este contenido es solo para fines informativos y no constituye asesoramiento de inversión. Siempre haga su propia investigación y consulte a un asesor financiero.
Recursos Oficiales
Datos proporcionados solo con fines informativos.
- Financial data is limited, particularly given the OTC listing and unknown disclosure status.
- AI analysis is pending, so some conclusions are based on limited available information.